vinyl chloride has been researched along with tamoxifen in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrews, LS; Bachman, AN; Boogaard, PJ; Cadet, J; Embry, MR; Farmer, PB; Himmelstein, MW; Jarabek, AM; Kim, JH; Martin, EA; Mauthe, RJ; Persaud, R; Pottenger, LH; Preston, RJ; Schoeny, R; Skare, J; Swenberg, JA; Williams, GM; Zeiger, E; Zhang, F | 1 |
1 review(s) available for vinyl chloride and tamoxifen
Article | Year |
---|---|
An organizational approach for the assessment of DNA adduct data in risk assessment: case studies for aflatoxin B1, tamoxifen and vinyl chloride.
Topics: Aflatoxin B1; Animals; Carcinogens; DNA Adducts; Dose-Response Relationship, Drug; Humans; Liver Neoplasms, Experimental; Mutagens; Mutation; Rats; Risk Assessment; Tamoxifen; Tissue Distribution; Vinyl Chloride | 2014 |